日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular mechanisms of flotillin complexes in organizing membrane microdomains

flotillin复合物在组织膜微区中的分子机制

Lu, Ming-Ao; Qian, Yunwen; Ma, Liangwen; Hong, Jinzhi; Li, Xiaopeng; Yu, Li; Guo, Qiang; Gao, Ning

Optogenetic engineering of synthetic and natural receptors: design principles, functional mechanisms and biomedical applications

合成和天然受体的光遗传学工程:设计原则、功能机制和生物医学应用

Zhao, Jiaying; Chen, Yani; Gao, BiCong; Zhang, Lujiao; Gao, Ning; Hao, Sijia; Gao, Zili; Cai, Wenjin; Yang, Jian; Yang, Guoli

Umbilical cord mesenchymal stromal cells-derived HGF inhibits STING-mediated pyroptosis to alleviate cerebral ischemia/reperfusion injury via c-Met/β-catenin/RNF5 pathway

脐带间充质干细胞来源的HGF通过c-Met/β-catenin/RNF5通路抑制STING介导的细胞焦亡,从而减轻脑缺血/再灌注损伤。

Tang, Hong; Gao, Ning; Gao, Ling; Li, You; Xia, Ying

Synthetic biology integrated with material science paves the way for next-generation smart cell therapies

合成生物学与材料科学的融合为下一代智能细胞疗法铺平了道路。

Zhao, Yue; Chuai, Yue; Fu, Kun; Han, Yirui; Gao, Ning; Nie, Guangjun; Chen, Yazhou

Recruitment of CCR5(+) inflammatory monocytes in pulmonary tissue contributes to acute lung injury.

肺组织中 CCR5(+) 炎症单核细胞的募集会导致急性肺损伤。

Wei Dongdong, Li Xuebiao, Xu Guocong, Sun Yupeng, Zhu Xian, Duan Qunjun, Gao Ning, Dong Aiqiang, Kong Minjian

Putative membrane protein Cgl2168 and its variant enhance thermotolerance in Corynebacterium glutamicum

推测的膜蛋白 Cgl2168 及其变体增强谷氨酸棒状杆菌的耐热性

Gao, Ning; Ni, Xiaomeng; Liu, Jiao; Chen, Jiuzhou; Wang, Yu; Zheng, Ping; Sun, Jibin

[Long non-coding RNA LASTR promotes progression of head and neck squamous cell carcinoma by binding to miR-4476 and upregulating BCAM expression]

[长链非编码RNA LASTR通过与miR-4476结合并上调BCAM表达来促进头颈部鳞状细胞癌的进展]

Wu, Bo; Song, Ru; Gao, Ning; Xing, Keyao; Zhang, Penghui; Qu, Moyi; Zhang, Huimin

Assessment of knowledge, attitude, and practice regarding diabetes among patients with type 2 diabetes in Hunan province, China: a cross-sectional study

中国湖南省2型糖尿病患者糖尿病知识、态度和行为评估:一项横断面研究

Chen, Guiyan; Gao, Ning; Huang, Jianwei; Pi, Linhua

Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial

安罗替尼联合信迪利单抗一线治疗晚期结直肠癌患者(APICAL-CRC):一项开放标签、单臂、II期试验

Wang, Zhan; Qin, Bao-Dong; Ye, Chen-Yang; Wang, Miao-Miao; Yuan, Ling-Yan; Yao, Hou-Shan; Jiao, Xiao-Dong; Liu, Ke; Zhou, Wen-Li; Qin, Wen-Xing; Sun, Li; Dai, Wei-Ping; Ling, Yan; Wu, Ying; Chen, Shi-Qi; Zhang, Ying-Fu; Shi, Dong-Min; Duan, Xiao-Peng; Zhong, Xue; He, Xi; Zhai, Wen-Xin; Zhang, Bei; Zhang, Da-Dong; Gao, Ning; Zang, Yuan-Sheng

Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study

新辅助disitamab vedotin (RC48-ADC)联合免疫疗法治疗肌层浸润性膀胱癌患者的疗效和生物标志物分析:一项多中心真实世界研究

Hu, Jiao; Yan, Luzhe; Liu, Jinhui; Chen, Minfeng; Liu, Peihua; Deng, Dingshan; Zhang, Chaobin; He, Yunbo; Fan, Benyi; Li, Huihuang; Gong, Guanghui; Xiao, Jiatong; Wang, Ruizhe; Guan, Xiao; Tong, Shiyu; Li, Yangle; Li, Nannan; Tang, Zhiwang; Zhang, Teng; Li, Hao; Huang, Bin; Gao, Ning; He, Wei; Cai, Zhiyong; Liu, Yifan; Liu, Zefu; Gan, Yu; Cui, Yu; Dai, Yuanqing; Cai, Yi; Nie, Zhenyu; Ou, Zhenyu; Chen, Jinbo; Zu, Xiongbing